Turkish Pharmaceutical Company Signs Export Contract with Turkmenistan

The Turkish pharmaceutical company “Türk İlaç ve Serum Sanayi A.Ş.” (TRILC) has signed an export contract with the Ministry of Health and Pharmaceutical Industry of Turkmenistan worth USD 4,994,137.50. The company announced this on December 26, 2025, via the Public Disclosure Platform (KAP), reports “Finans Anlık”.

According to the contract, the delivery of medicines and medical serums is planned. Shipments are expected to be completed in February 2026.

The report notes that orders are currently being accepted, and production and logistics will be carried out according to the approved schedule.

Headquartered in Ankara, “Türk İlaç ve Serum Sanayi A.Ş.” specializes in producing a wide range of pharmaceuticals and also engages in the export of pharmaceutical, veterinary, and cosmetic products, marketing, and representative services.